Details for New Drug Application (NDA): 217069
✉ Email this page to a colleague
The generic ingredient in PHENYLEPHRINE HYDROCHLORIDE is phenylephrine hydrochloride; promethazine hydrochloride. There are twenty-one drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the phenylephrine hydrochloride; promethazine hydrochloride profile page.
Summary for 217069
Tradename: | PHENYLEPHRINE HYDROCHLORIDE |
Applicant: | Mankind Pharma |
Ingredient: | phenylephrine hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 217069
Mechanism of Action | Adrenergic alpha1-Agonists |
Medical Subject Heading (MeSH) Categories for 217069
Suppliers and Packaging for NDA: 217069
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PHENYLEPHRINE HYDROCHLORIDE | phenylephrine hydrochloride | SOLUTION;INTRAVENOUS | 217069 | ANDA | Lifestar Pharma LLC | 70756-621 | 70756-621-25 | 25 VIAL in 1 CARTON (70756-621-25) / 1 mL in 1 VIAL (70756-621-82) |
PHENYLEPHRINE HYDROCHLORIDE | phenylephrine hydrochloride | SOLUTION;INTRAVENOUS | 217069 | ANDA | Lifestar Pharma LLC | 70756-622 | 70756-622-10 | 10 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70756-622-10) / 5 mL in 1 VIAL, PHARMACY BULK PACKAGE (70756-622-85) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 10MG/ML (10MG/ML) | ||||
Approval Date: | Aug 30, 2022 | TE: | AP1 | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 50MG/5ML (10MG/ML) | ||||
Approval Date: | Aug 30, 2022 | TE: | AP1 | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 100MG/10ML (10MG/ML) | ||||
Approval Date: | Aug 30, 2022 | TE: | AP1 | RLD: | No |
Complete Access Available with Subscription